Another Activist Investor Joins Calls For GSK Leadership Review
Bluebell Capital Has Already Ousted One CEO
Executive Summary
A second activist investor has called for GSK to consider replacing Emma Walmsley as CEO, and has underlined competitive threats to a key pipeline candidate.
You may also be interested in...
Pharma Past Propels Julie Brown To GSK’s CFO Position
GSK has poached its new chief financial officer from fashion brand Burberry, but Julie Brown’s experience at AstraZeneca and Roche will give her insights into how to lead GSK into its next phase.
Consumer Spin-Off Finally Achieved, GSK Will Weigh More M&A
GSK is entering a new era, and CEO Emma Walmsley looks likely to use new finances for more targeted M&A.
Q4 Earnings Preview: It's All About Growth Goals And Deal Plans (Part 2)
Industry's big players report fourth quarter results over the next two weeks. Updates on leadership changes, growth targets and deal plans are among the hot topics.